NCT00871156View on ClinicalTrials.gov

Tafenoquine/Chloroquine DDI Study

PHASE1CompletedINTERVENTIONAL

Enrollment

68

Participants

Timeline

Start Date

March 24, 2009

Primary Completion Date

August 26, 2009

Study Completion Date

August 26, 2009

Conditions

Malaria

Interventions

DRUG

Chloroquine, Tafenoquine

Chloroquine and Tafenoquine

DRUG

Placebo

Placebo

Trial Locations (1)

14202

GSK Investigational Site, Buffalo

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

collaborator

Medicines for Malaria Venture

OTHER

lead

GlaxoSmithKline

INDUSTRY